ABBOTT LABS logo

ABBOTT LABS (ABL)

Market Closed
7 Feb, 20:00
124. 70
+1.12
+0.91%
- Market Cap
36.49 P/E Ratio
2.2% Div Yield
0 Volume
4.44 Eps
123.58
Previous Close
Day Range
122.88 125.12
Year Range
90.08 128.28
Earnings results expected in 63 days

Summary

ABL closed Friday higher at €124.7, an increase of 0.91% from Thursday's close, completing a monthly increase of 14.11% or €15.42. Over the past 12 months, ABL stock gained 14.11%.
ABL pays dividends to its shareholders, with the most recent payment made on Nov 15, 2024. The next announced payment will be in In 3 days on Feb 14, 2025 for a total of €0.59.
The last earnings report, released on Jan 22, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Apr 15, 2025.
The stock of the company had never split.
The company's stock is traded on 14 different exchanges and in various currencies, with the primary listing on XBER (EUR).
Want to track ABL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

ABL Chart

FAQ

What Is the ABBOTT LABS(ABL) Stock Price Today?

The ABL stock price today is €124.70.

What Stock Exchange Does ABBOTT LABS Trade On?

ABBOTT LABS is listed and trades on the NYSE.

What Is the Stock Symbol for ABBOTT LABS?

The stock symbol for ABBOTT LABS is "ABL".

Does ABBOTT LABS Pay Dividends? What's The Current Dividend Yield?

ABL is not paying dividends to its shareholders.

What Is the ABBOTT LABS Market Cap?

As of today, ABBOTT LABS does not have a market cap available.

What is ABBOTT LABS Earnings Per Share?

The ABBOTT LABS EPS is 0.

What Is the Next ABBOTT LABS Earnings Date?

ABBOTT LABS will release its next earnings report on Apr 15, 2025.

Did ABBOTT LABS had any splits?

No, ABBOTT LABS has never had a stock split.

ABBOTT LABS Profile

Medical Devices Industry
Healthcare Sector
Mr. Robert B. Ford CEO
XBER Exchange
US0028241000 ISIN
United States Country
114,000 Employees
15 Jan 2025 Last Dividend
2 Jan 2013 Last Split
13 Jan 1978 IPO Date

Overview

Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.

Products and Services

Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:

  • Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
  • Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
  • Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
  • Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.

Contact Information

Address: 100 Abbott Park Road
Phone: 224 667 6100